GSDMD and age-related macular degeneration: Furthermore, as the release point for pro-inflammatory cytokines, impairing GSDMD-mediated pore formation and subsequent pyroptosis presents a therapeutic opportunity, given the strong association between pro-inflammatory cytokine IL-1β and AMD disease pathogenesis [8, 17, 35].